Procedure Deep-Dive · June 6, 2026
Do Breast Implants Need to Be Replaced Every 10 Years? The Rule That Was Never a Rule
The idea that breast implants need to be replaced every ten years is one of the most durable myths in cosmetic surgery, and it costs patients money and operating-room time they may not owe. Here is what actually drives a replacement decision, what the FDA genuinely recommends, and why the age of the device is one of the least useful numbers in the conversation.
By The Editorial Desk
5 min read

The single most repeated sentence about breast implants is also one of the least accurate: that they need to be replaced every ten years. Patients hear it in consultation rooms, read it on forums, and arrive at follow-up appointments braced for a surgery they assume is overdue. So do breast implants need to be replaced on a fixed schedule? No. There is no ten-year rule, there never was an official one, and treating the calendar as the trigger for a second operation gets the entire question backward. Implants are not lifetime devices, but the decision to exchange them is driven by what is happening in a specific breast, not by how many birthdays the implant has had.
Where the ten-year number came from
The "every ten years" figure is a misremembered statistic, not a guideline. It traces loosely to manufacturer warranty windows and to early data showing that a meaningful share of patients undergo some kind of revision within a decade. That is a very different claim from "all implants expire at ten years." A revision rate of, say, twenty percent over ten years also means roughly eighty percent of patients did not need one in that window. The number describes a probability across a population, and it got flattened into a deadline applied to every individual.
The clinical reality is more boring and more reassuring. As Dr. Emil Kohan's clinic notes on its post about aging implants: "Understanding the longevity of your devices starts with recognizing that there is no expiration date that applies to every patient." Some women keep their original implants for thirty years without a problem. Others need a revision in three. The variable is the breast and the device in front of you, not the year stamped on the chart.
What the FDA actually recommends
This is where patients deserve the precise version, because the real guidance is specific and it has nothing to do with routine replacement. The U.S. Food and Drug Administration recommends that women with silicone gel implants undergo imaging to screen for "silent rupture," a leak with no outward symptoms. The current FDA guidance suggests the first ultrasound or MRI around five to six years after surgery, then repeating every two to three years thereafter.
Read that carefully. The recommendation is to monitor, not to replace. The FDA is telling patients to check whether the implant is intact, because a silicone rupture can be silent and is best caught on imaging rather than by feel. A saline implant that ruptures, by contrast, announces itself: the shell deflates and the body absorbs the harmless saltwater, so the change is visible within days. Neither scenario is governed by a ten-year clock. One is governed by a screening schedule, the other by an obvious deflation.
"The age of an implant is one of the least useful numbers in the room. A twenty-year-old implant that is intact and looks good needs nothing. A four-year-old implant with a silent rupture needs attention now. The calendar is not the patient.
"
The signals that actually matter
A genuine replacement conversation starts with clinical indicators, not the date of the original surgery. The reasons women come back to the operating room fall into a short, identifiable list:
- Rupture. A silicone silent rupture found on imaging, or a saline deflation visible to the eye.
- Capsular contracture. The scar tissue around the implant tightens and hardens, distorting shape and sometimes causing discomfort. This is one of the more common reasons for revision and is unrelated to implant age.
- Visible or palpable change. Rippling, malposition, or a shift in shape and feel as the breast tissue and skin change with time.
- Aesthetic evolution. A patient simply wants a different size or profile than the one chosen years earlier, which is a legitimate reason that has nothing to do with anything failing.
The useful framing is to evaluate the device, not the date. As the clinic puts it, "The team at EmilMD focuses on identifying specific clinical indicators rather than relying solely on the age of the device." That is the correct order of operations. A surgeon who books a replacement because an implant "hit ten years," with no symptom and no imaging finding, is solving a problem the patient may not have.
Monitoring beats replacing
The practical takeaway is that the right behavior for most women with older implants is not preemptive surgery. It is staying in the screening loop. The American Society of Plastic Surgeons advises ongoing follow-up and imaging for implant patients precisely so that the genuine problems (rupture, contracture, malposition) are caught early, while the implant is still doing its job. Diligence is the substitute for a deadline.
That diligence costs almost nothing and avoids two opposite errors. The first error is replacing an implant that did not need it, paying for surgery and accepting anesthesia and recovery risk to fix something that was not broken. The second is ignoring an implant entirely, skipping imaging, and missing a silent rupture for years. The patients who do best sit between those poles: they monitor on the FDA's schedule, they keep their follow-up appointments, and they act when there is something specific to act on.
The honest summary
Do breast implants need to be replaced every ten years? No. They are not lifetime devices, and many patients will eventually have a revision for rupture, capsular contracture, a visible change, or a shift in what they want. But the trigger is a clinical finding, not an anniversary. The FDA's actual recommendation is to screen silicone implants with ultrasound or MRI starting around five to six years out and then every two to three years, which is guidance to monitor, not a schedule to replace. For patients trying to make sense of an aging device, how Dr. Emil Kohan's practice evaluates older breast implants is a reasonable description of the right approach: look at the implant, the imaging, and the patient's goals, and let those decide, rather than counting years off a calendar that was never a rule in the first place.
Editor's Note
Further reading on this topic: how Dr. Emil Kohan's practice evaluates older breast implants.